Clinical Trials in Phoenix

Showing 601-620 of 14,291 trials

ETNA-MS Device Validation Study

NCT06256731

The overarching goal of this research protocol is to validate the effectiveness of Innodem's ETNA-MS device in informing clinicians on the disability status of Multiple Sclerosis (MS) patients. Effectiveness of the device will be assessed by the level of agreement between the EDSS estimated by the device and the actual scores measured by the neurologist in-person assessments.

Multiple Sclerosis

Innodem Neurosciences60 participantsStarted Dec 2023

Phoenix, Arizona, United States • Farmington Hills, Michigan, United States • Owosso, Michigan, United States +2 more locations

RECRUITINGPhase 2< 1 mile

A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Years With Alcohol-related Liver Disease

NCT06613698

The goal of this study is to assess the safety and efficacy of GSK4532990 in participants with alcohol-related liver disease.

Liver Diseases, Alcoholic

GlaxoSmithKline393 participantsStarted Sep 2024

Chandler, Arizona, United States • Phoenix, Arizona, United States • Tucson, Arizona, United States +128 more locations

ETNA-MS Device Validation Study

A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Years With Alcohol-related Liver Disease

Find Trials by Condition in Phoenix

Dose-Ranging Study of the Efficacy and Safety of TAK-101 for Prevention of Gluten-Specific T Cell Activation in Participants With Celiac Disease on a Gluten-Free Diet

A Phase 3 Study to Evaluate the Safety and Tolerability of L606 in Subjects With PAH or PH-ILD

Azacitidine With or Without Lenalidomide or Vorinostat in Treating Patients With Higher-Risk Myelodysplastic Syndromes or Chronic Myelomonocytic Leukemia

A Randomized Study of Azetukalner Versus Placebo in Depressive Episodes Associated With Bipolar I or II Disorder (Bipolar Depression)

A Study to Investigate the Safety, Tolerability, Drug Levels and Drug Effects of BMS-986326 in Adult Participants With Different Forms of Lupus

Erenumab - Comprehensive Assessment of Efficacy in (High-Frequency) Episodic Migraine

Efficacy and Safety of Odevixibat in Children With Biliary Atresia Who Have Undergone a Kasai HPE (BOLD)

DECAMP-2: Screening of Patients With Early Stage Lung Cancer or at High Risk for Developing Lung Cancer

Testing the Addition of the Immune Therapy Drugs, Tocilizumab and Atezolizumab, to Radiation Therapy for Recurrent Glioblastoma

Long-term Safety and Efficacy of Odevixibat in Patients With Alagille Syndrome

Pemetrexed Disodium and Cisplatin With or Without Cediranib Maleate in Treating Patients With Malignant Pleural Mesothelioma

A Clinical Study of Pembrolizumab (+) Berahyaluronidase Alfa (MK-3475A) to Treat Newly-diagnosed Metastatic Non-small Cell Lung Cancer (MK-3475A-F84)

A Phase 2 Study of ONO-2808 in Patients With Multiple System Atrophy

Clinical Study To Further Evaluate The Efficacy Of Dabrafenib Plus Trametinib In Patients With Rare BRAF V600E Mutation-Positive Unresectable or Metastatic Solid Tumors

A Study of AB801 Monotherapy and Combination Therapy in Participants With Advanced Malignancies

Checklist to Prevent MRSA Surgical Site Infections

Prophylactic DR-CPAP on Late Preterm Infants Born by C-section: an RCT

Astroscape: A Study of Radiprodil on Safety, Tolerability, Pharmacokinetics, and Effect on Seizures and Behavioral Symptoms in Patients With TSC or FCD Type II